Article Text

Download PDFPDF
Randomised controlled trial
Probiotics reduce the risk of necrotising enterocolitis (NEC) in preterm infants
  1. Nicholas Embleton,
  2. Janet E Berrington
  1. Newcastle Neonatal Service, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
  1. Correspondence to Dr Nicholas D Embleton
    Newcastle Neonatal Service, Newcastle Hospitals NHS Foundation Trust, Richardson Road, Newcastle upon Tyne NE1 4LP, UK; nicholas.embleton{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


Survival rates for preterm infants have increased dramatically over the last two decades, but necrotising enterocolitis (NEC) remains a major problem. Around 30–50% of NEC-affected infants require surgery, approximately 30% may die, and survivors have increased risks of adverse neurodevelopmental sequelae. NEC has a multifactorial aetiology, and may represent the end stage of a variety of pathological processes, but in many cases appears strongly associated with patterns of gut microbial colonisation.1 Probiotics are the live bacteria that confer a health benefit; most are from the genus Lactobacilli or Bifidobacterium. Several recent meta-analyses have suggested probiotics reduce the risk …

View Full Text


  • Competing interests None.